Published in BMC Cancer on January 03, 2017
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet (2006) 5.62
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet (2003) 3.63
A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell (1992) 3.46
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res (2001) 3.21
SATB1 targets chromatin remodelling to regulate genes over long distances. Nature (2002) 3.10
SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell (2009) 2.57
The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev (2000) 2.49
The serine/threonine kinase Pim-1. Int J Biochem Cell Biol (2005) 2.32
Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol (2006) 2.29
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int (2012) 2.02
β-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol Ther (2011) 1.73
Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev (2009) 1.67
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther (2008) 1.61
SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep (2010) 1.56
An angiogenic growth factor is expressed in human glioma cells. EMBO J (1987) 1.46
Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis (2011) 1.40
p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol (2011) 1.39
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol (2012) 1.38
A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Release (2006) 1.37
Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS (2010) 1.37
Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec (2010) 1.29
Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med (2012) 1.24
Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci (2011) 1.20
Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol (2004) 1.14
β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. Med Oncol (2010) 1.08
Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. J Neurooncol (2007) 1.04
SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS One (2013) 1.04
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med (2010) 1.01
Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS One (2013) 0.99
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro Oncol (2011) 0.99
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res (2012) 0.98
Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development. Mol Cell Biol (2011) 0.96
AT-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma. Oncol Lett (2012) 0.96
Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma. Neoplasia (2013) 0.94
EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors. Oncogene (2013) 0.94
Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World J Gastroenterol (2013) 0.93
Inter-MAR association contributes to transcriptionally active looping events in human beta-globin gene cluster. PLoS One (2009) 0.90
Phosphorylated SATB1 is associated with the progression and prognosis of glioma. Cell Death Dis (2013) 0.89
Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma. Int J Cancer (2014) 0.85
Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene (2015) 0.82
Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Mol Med Rep (2012) 0.80
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma. Mol Cancer (2011) 0.78
SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. Dig Dis Sci (2015) 0.78
Relationship between SATB1 expression and prognosis in astrocytoma. J Clin Neurosci (2013) 0.77
Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues. Tumour Biol (2015) 0.77
Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis. Jpn J Clin Oncol (2015) 0.76